Sienna Biopharmaceuticals, Inc.
CIK 0001656328
Revenue (TTM)
$0
Q3 Nov 2019
Net Income (TTM)
−$45.41M
−15.1% YoY
Q3 Nov 2019
EPS Diluted (TTM)
—
Q3 Nov 2019
Gross Margin
—
Q3 Nov 2019
Operating Margin
—
Q3 Nov 2019
Net Margin
—
Q3 Nov 2019
Free Cash Flow (TTM)
−$61.73M
Q3 Nov 2019
Cash
$11.33M
Q3 Nov 2019
Total Debt
$29.47M
Q3 Nov 2019
Shares Outstanding
30.91M sh
Q3 Nov 2019
Revenue & Net Income
Cash Flow
Revenue Growth (YoY)
No data available for this metric.